HighTower Advisors LLC Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
HighTower Advisors LLC purchased a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 13,460 shares of the company’s stock, valued at approximately $1,139,000. Several other hedge funds and other institutional investors have also […]
